Arix Bioscience Plc
10% Owner
1 company
Arix Bioscience Plc is a 10% Owner at Enliven Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $62.8M based on current market prices.
Holdings by Company
ELVNMar 16, 2020
Current Shares1.37M
Value$62.83M
Net Activity+187.5K
Bought: 187.5KSold: 0
Transaction History
Showing 1 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2020 | ELVN Enliven Therapeutics, Inc. | 10% Owner | Buy | 187,500 | $16.00 | $3,000,000.00 | +13.7% |